Brewin Dolphin MISM funds shift to UK value overweight on vaccine bounce

Cyclical stocks positioned 'to do well'

Brewin Dolphin's MI Select Managers (MISM) funds have moved to an overweight position in UK equity funds and are targeting opportunities in small-cap value strategies, as head of central investment solutions David Hood anticipates a supportive environment arising from the country's vaccine roll-out and emergence from lockdown.

Hood told Investment Week the MISM range is positioning for cyclical stocks "to do well as vaccines come through". The MI Select Managers UK equity strategy, which Brewin Dolphin runs as part of its model portfolio service, has recently dropped the Premier Miton UK Smaller Companies fund in favour of the £75m Teviot UK Smaller Companies offering.  Brewin Dolphin total funds surpass pre-Covid highs "It is a small-cap value strategy, which is pretty unusual. When you are thinking of small caps, you are usually thinking about growth, but it complements another mid-cap strategy we have...